Last Updated: September 27, 2026

Details for Patent: 11,497,750

Name: Drug Patent Intelligence for US Patent 11497750
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 11,497,750 protect, and when does it expire?

Patent 11,497,750 protects KLISYRI and is included in one NDA.

This patent has thirty-two patent family members in twenty-three countries.

Summary for Patent: 11,497,750

Title:	Methods of treating and/or preventing actinic keratosis
Abstract:	The application pertains to methods of treating and/or preventing actinic keratosis, comprising administering a therapeutically effective amount of KX-01,to a subject in need thereof.
Inventor(s):	Min-Fun Rudolf KWAN, Johnson Yiu-Nam Lau, E. Douglas KRAMER, David Lawrence CUTLER, Jane FANG
Assignee:	Atnx Spv LLC , Atnx Spv LLC United States
Application Number:	US16/804,092
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 11,497,750
Patent Claim Types: see list of patent claims	Use;

Drugs Protected by US Patent 11,497,750

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Almirall	KLISYRI	tirbanibulin	OINTMENT;TOPICAL	213189-001	Dec 14, 2020		RX	Yes	Yes	11,497,750	⤷ Start Trial				TOPICAL TREATMENT OF ACTINIC KERATOSIS OF THE FACE OR SCALP	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 11,497,750

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2018231144	⤷ Start Trial
Australia	2024201828	⤷ Start Trial
Brazil	112019018687	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.